Forte Biosciences, Inc. (NASDAQ:FBRX) announced a significant change in its capital structure today, as it executed a reverse stock split of its common stock. The pharmaceutical company, which is ...
The reverse stock split also necessitated proportional adjustments in the company's equity incentive plans. This includes the Tocagen (NASDAQ: FBRX) Inc. 2009 Equity Incentive Plan, the 2017 Equity ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results